AVAH stock news today

Aveanna Healthcare reports Q3 2026 results and revised guidance

Aveanna Healthcare released its third quarter 2026 financial results along with updated guidance. The company revised its outlook for the period.

Aveanna Healthcare lifts FY26 adjusted EBITDA guidance to above $374M from above $365M

Aveanna Healthcare increased its full-year 2026 adjusted EBITDA forecast to more than $374 million, up from its earlier target of over $365 million. The change points to a higher earnings outlook for the year.

Form 8-K tells shareholders about important events such as deals, leadership changes or results.

Aveanna Healthcare projects FY2026 revenue above $2.695B, topping $2.693B estimate

Aveanna Healthcare said it expects fiscal 2026 revenue to exceed $2.695 billion. That is slightly above the $2.693 billion analyst estimate.

JP Morgan keeps Neutral rating on Aveanna Healthcare, lifts price target to $15

JP Morgan stayed Neutral on Aveanna Healthcare Holdings while raising its price target to $15. The update reflects the firm's latest view on the company's shares.

Barclays keeps Overweight rating on Aveanna Healthcare, lifts target to $15

Barclays reiterated its Overweight rating on Aveanna Healthcare Holdings and raised its price target to $15. The update reflects the analyst's revised view of the stock.

Form 4 reports shares bought or sold by company insiders such as officers, directors or large holders.

Truist Securities keeps Hold rating on Aveanna Healthcare, lifts price target to $15

Truist Securities reiterated a Hold rating on Aveanna Healthcare Holdings while raising its price target to $15. The update reflects the firm's revised view of the stock's value.

RBC Capital raises Aveanna Healthcare price target to $16 from $10

RBC Capital kept its Outperform rating on Aveanna Healthcare and lifted its price target to $16 from $10. The stock traded higher after the analyst update.

RBC Capital keeps Outperform rating on Aveanna Healthcare, lifts target to $16

RBC Capital reiterated its Outperform rating on Aveanna Healthcare Holdings and raised its price target to $16. The update reflects the analyst's revised expectations for the company.

Aveanna Healthcare sets $11.75 price for 15 million-share stock sale

Aveanna Healthcare said a sale of 15 million of its shares will be priced at $11.75 each. Its stock fell following that announcement.

Aveanna sets $11.75 per share for 15M-share resale

Aveanna Healthcare fixed the price for a resale of 15 million common shares at $11.75 each. Such a resale involves stock changing hands rather than newly issued shares.

Aveanna Healthcare to sell 15 million shares in new stock sale

Aveanna Healthcare Holdings disclosed a new stock sale involving 15 million shares. Its shares moved lower after the news came out.

Aveanna launches secondary offering of 15 million shares

Aveanna said it is starting a secondary offering of 15 million shares. A secondary offering typically involves existing shareholders selling stock rather than the company issuing new shares.

UBS keeps Neutral rating on Aveanna Healthcare, lifts price target to $13

UBS maintained its Neutral rating on Aveanna Healthcare Holdings while raising its price target to $13. The update reflects the analyst's revised view of the stock's value.

Raymond James keeps Strong Buy on Aveanna Healthcare, lifts target to $15

Raymond James reiterated its Strong Buy rating on Aveanna Healthcare Holdings and raised its price target to $15. The update reflects the firm's latest view on the company's shares.

BMO Capital keeps Outperform on Aveanna Healthcare, lifts target to $14

BMO Capital reiterated its Outperform rating on Aveanna Healthcare and increased its price target to $14 from $10. The stock traded higher following the analyst update.

What is the latest news on AVAH?

Nov 12, 2026: Aveanna Healthcare reports Q3 2026 results and revised guidance (Fiscal.ai) · Nov 12, 2026: Aveanna Healthcare lifts FY26 adjusted EBITDA guidance to above $374M from above $365M (Benzinga) · Nov 12, 2026: Aveanna Healthcare Holdings, Inc. filed a report on a major company event (Form 8-K) (SEC)

What has AVAH filed with the SEC recently?

Nov 12, 2026: Aveanna Healthcare Holdings, Inc. filed a report on a major company event (Form 8-K) · Aug 24, 2026: Aveanna Healthcare Holdings, Inc. filed an insider trading report (Form 4)